Bio-Rad Laboratories, Inc. BIO | NYSE
Company Overview:
10 Year Performance Metrics:
Unlock All Reports & Research Dividend Stocks like a BOSS!
BIO Earnings, Revenue, Cash & Debt, Shares Outstaning:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
Projected Future Returns & Dividends for BIO
Based on past 10-year performance, here are BIO growth metrics:
Share price CAGR of +5.94%
Dividend CAGR of +0%
Using BIO CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| BIO (DRIP) | BIO - No DRIP | |
|---|---|---|
| Current Price | $240.43 | $240.43 |
| Start Shares | 41.59 | 41.59 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 41.59 | 41.59 |
| Dividends Payment | $0.00 | $0.00 |
| Annual Dividends | $0 | $0 |
| Yield on cost | 0.00% | 0.00% |
| Share Price | $404.29 | $240.43 |
| Total Dividends | $0 | $0 |
| Final Value | $16,815 | $10,000 |
NOTE: Above numbers are our estimate based on BIO's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Company Info
Bio-Rad Laboratories, Inc. (BIO) had its IPO on 1980-02-27, and is trader on NYSE stock exchange.
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
BIO website: https://www.bio-rad.com
